Bernie Sanders Wants to Meet Novo CEO Next Week on Ozempic Price

Senator Bernie Sanders wants to meet next week with Novo Nordisk A/S’s top executive about lowering the price of its blockbuster drug Ozempic, fueling controversy over the costs of GLP-1 drugs for diabetes and obesity.

The Vermont independent said he’s considering hearings on the cost of GLP-1 drugs like Ozempic, but first wants to personally discuss their prices with Novo Chief Executive Officer Lars Fruergaard Jørgensen.

Bernie Sanders

Photographer: Alex Wong/Getty Images

“We are going to try to make it happen next week,” said Sanders, chair of the Senate Health, Education, Labor and Pensions committee. Ozempic lists in the US for $968.52 ...